Semaglutide is a drug that has been gaining a lot of attention in the medical and scientific community as a potential treatment for obesity. The drug works by mimicking a hormone released when we eat, which tricks the brain into feeling full, significantly reducing a person's appetite. Studies have shown that when used in tandem with a healthy lifestyle, semaglutide can result in an average of 15% body weight loss over the course of a year. However, the weight often returns once the drug is stopped, with long-term studies showing that two-thirds of lost weight is regained within two years.
The drug's use has been controversial, with some experts arguing that it should not be used as a long-term solution, but merely as a short-term measure to help individuals in need. Others argue that given the prevalence of overweight and obese individuals, and the failure of government policies to address the issue, semaglutide should be used as part of a comprehensive strategy to tackle the problem.
The debate around semaglutide raises further questions about the role of celebrity culture, the availability of semaglutide through online-only consultations, and the potential impact on eating disorders. There is no easy answer, but it is clear that the debate around this drug, and the hype surrounding it, is not going away anytime soon.